4D Biomaterials

company

About

4D Biomaterials manufactures polymer resins for 3D-printing high resolution biodegradable medical devices.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
£1.60M
Industries
Biotechnology,Health Care,Manufacturing,Medical Device
Founded date
Oct 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

4Degra® is a unique, patent-protected platform technology and is the ONLY route to 3D-printing high resolution biodegradable medical devices. The technology boosts excellent 3D-printing resolution, unique tunability in strength, elasticity and biodegrability as well as outstanding shape memory properties. Game-changing properties in themselves PLUS the ability to 3D-print medical devices from nano to macro scale will lead to far superior patient experiences compared with the next best alternatives.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£1.60M
4D Biomaterials has raised a total of £1.60M in funding over 2 rounds. Their latest funding was raised on Jul 28, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 28, 2021 Seed £1.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
4D Biomaterials is funded by 1 investors. Mercia Fund Managers are the most recent investors.
Investor Name Lead Investor Funding Round
Mercia Fund Managers Seed